期刊文献+

万古霉素壳聚糖缓释微球的制备及其体外释药特性和抑菌作用研究 被引量:4

Preparation of Vancomycin-loaded Chitosan Sustained-release Microspheres and Its Drug Release in vitro and Antibacterial Effect
下载PDF
导出
摘要 目的:制备万古霉素壳聚糖缓释微球,考察其体外释药特性和抑菌作用。方法:采用乳化交联法制备万古霉素壳聚糖缓释微球,观察微球的粒径分布及形态;应用紫外分光光度法测定微球药物含量,计算载药量及包封率;通过体外释放试验,比较其与盐酸万古霉素24 h内的体外释药情况,考察其7 d内的累积释放度(Q);通过体外抑菌试验观察其作用20 d对金黄色葡萄球菌抑菌圈直径的影响。结果:所制万古霉素壳聚糖缓释微球呈圆球形,表面圆整,无明显凹凸和孔隙,平均粒径为(165.6±19.7)μm,平均载药量为(32.6±3.2)%,平均包封率为(53.8±6.3)%,Q_(7d)为82.7%;其与盐酸万古霉素的Q_(2h)分别为18.6%、91.3%;其作用1 d时的抑菌圈直径>3 cm,随其作用时间的延长,抑菌圈直径逐渐缩小。结论:成功制得万古霉素壳聚糖缓释微球,其体外缓释效果明显,且具有良好的体外抑菌作用。 OBJECTIVE: To prepare vancomycin-loaded chitosan sustained-release microspheres and to study its drug release and antibacterial effects in vitro. METHODS: The emulsion cross-linking was used to prepare vancomycin-loaded chitosan sus- tained-release microspheres, and the particle size and morphology of microspheres were observed. The contents of vancomycin in microspheres was determined by UV spectrophotometry, and drug-loading amount of entrapment efficiency were calculated. Drug release of prepared microspheres and vancomycin hydrochloride within 24 h were compared by release trial in vitro, and then its ac- cumulative release rate (Q) within 7 d was investigated. The effects of prepared microspheres on the diameter of inhibition zone to Staphylococcus aureus after treated for 20 d were observed through in vitro antibacterial test. RESULTS: The microspheres were spherical and complete round without obvious bump and pore. The average particle size of the microspheres was (165.6 ±19.7)μm; average drug-loading amount was (32.6 ±3.2) % ; average encapsulation efficiency was (53.8± 6.3) % ; Q7 d was 82.7%. Q2 h of prepared microspheres and vancomycin hydrochloride were 18.6% and 91.3%. The diameter of inhibition zone was higher than 3 cm after treated for 1 d, and then decreased gradually as time. CONCLUSIONS: Vancomycin-loaded chitosan sustained-release microspheres can be prepared successfully, and show obvious in vitro sustained-release effect and antibacterial effects.
出处 《中国药房》 CAS 北大核心 2016年第31期4443-4445,共3页 China Pharmacy
关键词 万古霉素 壳聚糖 微球 体外释药 体外抑菌 Vancomycin Chitosan Microsphere Release in vitro Antibacterial effect in vitro
  • 相关文献

参考文献13

  • 1Varma S,Sadasivan C. A long acting biodegradable con-trolled delivery of chitosan microspheres loaded with teta-nus toxoide as model antigen[J].Biomedicine & Pharma-cotherapy ,2014,68(2):225.
  • 2Li X, Ouyang J,Yang H,et al. Chitosan modified halloy-site nanotubes as emerging porous microspheres for drugcarrier[J].Applied Clay Science,2016, doi: 10.1016/j.clay.2016.03.035.
  • 3Zhang J, Tang Q, Xu X, et al Development and evalua-tion of a novel phytosome-loaded chitosan microspheresystem for curcumin delivery[J].International Journal ofPharmaceutics ,2013,448 (1) : 168.
  • 4冯淑莹,李国明,侯琼,石光.金雀异黄素/壳聚糖微球的制备及其释药性能[J].华南师范大学学报(自然科学版),2013,45(5):64-67. 被引量:8
  • 5Doty HA, Leedy MR, Courtney HS, et al. Compositechitosan and calcium sulfate scaffold for dual delivery ofvancomycin and recombinant human bone morphogeneticprotein-2[J].Journal of Materials Science.. Materials inAfeiizcme,2014,25(6) : 1 449.
  • 6Meng D, Dong L,Wen Y,et al. Effects of adding resorb-able chitosan microspheres to calcium phosphate cementsfor bone regeneration[J].Materials Science and Engineer-ing i C,2015,doi: 10.1016/j.msec.2014.11.049.
  • 7Bitencourt CS, da Silva LB, Pereira PAT, et al. Micro-spheres prepared with different co-polymers of poly (lac-tic-glycolic acid) (PLGA) or with chitosan cause distincteffects on macrophages[J], Colloids and Surfaces B: Bio-2015, doi : 10.1016/j.colsurfb.2015.10.011.
  • 8Xie M,Zeng L, Zhang Q, et al. Synthesis and adsorptionbehavior of magnetic microspheres based on chitosan/or-ganic rectorite for low-concentration heavy metal removal[J].Journal of Alloys and Compounds, 2015,doi : 10.1016/j.jallcom.2015.06.065.
  • 9王明波,冯庆玲.乳酸-乙醇酸共聚物/壳聚糖复式微球缓释蛋白[J].复合材料学报,2011,28(5):20-26. 被引量:5
  • 10汪小乐,简晓顺,庞廷媛,程国华.叶酸偶联壳聚糖载多西他赛纳米粒的制备[J].中国药房,2014,25(29):2740-2743. 被引量:6

二级参考文献32

  • 1王剑波,顾宜,郭萍,高容.紫外分光光度法测定染料木素胶囊含量及溶出度[J].药物分析杂志,2004,24(5):473-476. 被引量:14
  • 2丘晓琳,李国明,叶俊生.低分子肝素/壳聚糖/海藻酸钠复合微囊的制备及释药性能[J].应用化学,2005,22(4):361-366. 被引量:17
  • 3柳时,徐喆,罗智,项光亚.叶酸偶联壳聚糖纳米粒的制备[J].医药导报,2006,25(6):561-563. 被引量:21
  • 4吕彩霞,姚子华.纳米羟基磷灰石/壳聚糖-硫酸软骨素复合材料的制备及其性能研究[J].复合材料学报,2007,24(1):110-115. 被引量:28
  • 5Giteau A, Venier-Julienne M C, Aubert-Pouessel A, et al. How to achieve sustained and complete protein release from PLGA-based microparticles [J]. International Journal of Pharmaceutics, 2008, 350(1/2): 14-26.
  • 6Sinha V R, Trehan A. Biodegradable microspheres for protein delivery Journal of Controlled Release, 2003, 90(3): 261-280.
  • 7Lam X M, Duenas E T, Daugherty A L, et al. Sustained release of recombinant human insulin-like growth factor Ⅰ : For treatment of diabetes [J]. Journal of Controlled Release, 2000, 67(2/3): 281-292.
  • 8Sinha V R, Singla A K, Wadhawan S, et al. Chitosan microspheres as a potential carrier for drugs [J]. International Journal of Pharmaceutics, 2004, 274(1/2): 1-33.
  • 9Wang Mingbo, Feng Qingling, Niu Xufeng, et al. A spheres-in-sphere structure for improving protein-loading poly- (lactide-co-glycolide) microspheres [J]. Polymer Degradation and Stability, 2010, 95(1): 6-13.
  • 10Di Toro R, Betti V, Spampinato S. Biocompatibility and integrin-mediated adhesion of human osteoblasts to poly(DL-lactide-co-glycolide) copolymers [J]. European Journal of Pharmaceutical Sciences, 2004, 21(2/3): 161-169.

共引文献16

同被引文献33

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部